Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
4.900
+0.260 (5.60%)
Apr 1, 2026, 4:00 PM EDT - Market closed
Bicycle Therapeutics Market Cap
Bicycle Therapeutics has a market cap or net worth of $341.56 million as of April 2, 2026. Its market cap has decreased by -48.42% in one year.
Market Cap
341.56M
Enterprise Value
-269.69M
1-Year Change
-48.42%
Ranking
Category
Stock Price
$4.90
Market Cap Chart
Since May 23, 2019, Bicycle Therapeutics's market cap has increased from $212.36M to $341.56M, an increase of 60.84%. That is a compound annual growth rate of 7.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 341.56M | -30.45% |
| Dec 31, 2025 | 491.12M | -49.19% |
| Dec 31, 2024 | 966.64M | 26.03% |
| Dec 29, 2023 | 766.98M | -12.72% |
| Dec 30, 2022 | 878.81M | -50.89% |
| Dec 31, 2021 | 1.79B | 367.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polaryx Therapeutics | 359.81M |
| PureTech Health | 356.13M |
| NervGen Pharma | 347.27M |
| DiaMedica Therapeutics | 345.93M |
| Immuneering | 344.60M |
| Puma Biotechnology | 343.93M |
| Neurogene | 337.34M |
| Opus Genetics | 333.69M |